XU Qin , SUN Qi
  • Consulting Office of Medical Statistics, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China;
XU Qin, Email: xuqin6140@126.com
STARD statement; Evaluation; Diagnostic accuracy; Lung cancer; TuM2-PK
10.7507/1672-2531.20090022
Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables References Cited by

Objective 　To evaluate whether the paper titled “Application of tumor type M2 pyruvate kinase in the diagnosis of lung cancer” met the standards set in the STARD statement.
Methods 　Based on each of the 25 items of STAndards for the Reporting of Diagnostic accuracy studies (STARD statement), the paper titled “Application of tumor type M2 pyruvate kinase in the diagnosis of lung cancer” was checked and evaluated.
Results 　In the paper titled “Application of tumor type M2 pyruvate kinase in the diagnosis of lung cancer”, the reporting of 1 item of the STARD statement was adequately standardized, 7 items were relatively standardized, 5 items were inadequately standardized, 2 items were not standardized, and the other 10 were not reported.
Conclusion 　 Generally speaking, the reporting of diagnostic accuracy studies has not been standardized adequately in China. The methodological quality and applicability of diagnostic accuracy studies should be improved.

Citation： XU Qin,SUN Qi. Evaluation of the Paper Titled “Application of Tumor Type M2 Pyruvate Kinase in Diagnosis of Lung Cancer” Based on the STARD Statement. Chinese Journal of Evidence-Based Medicine, 2009, 09(1): 113-118. doi: 10.7507/1672-2531.20090022 Copy

Copyright © the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved

  • Previous Article

    Evidence-based Clinical Treatment of diabetic peripheral neuropathy LIJunfeng, WEN Chongyuan

  • Next Article

    From Randomized Controlled Trials to Evidence Grading Schemes: Current State of Evidence-based Practice in Social Sciences RobertBoruch, 芮宁